Selected research
Market Structure
Global Maternal Mental Health Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Maternal Mental Health market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Maternal Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Maternal Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Maternal Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Maternal Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Maternal Mental Health include Lipocine, Pfizer, Viatris, Bold Health, Glaxo Smith Kline Inc., Alembic Pharmaceuticals Limited, Mallinckrodt, Sage Therapeutics, Inc. and Bausch Health Companies Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Maternal Mental Health market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Maternal Mental Health and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Maternal Mental Health revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Maternal Mental Health market size, projected growth trends, production technologies, key applications, and end-use industries.
Maternal Mental Health Segment by Company
Lipocine
Pfizer
Viatris
Bold Health
Glaxo Smith Kline Inc.
Alembic Pharmaceuticals Limited
Mallinckrodt
Sage Therapeutics, Inc.
Bausch Health Companies Inc.
Magellan Health
Maternal Mental Health Segment by Type
Antidepressants
Interpersonal Psychotherapy
Cognitive Behavioural Therapy
Others
Maternal Mental Health Segment by Application
Clinics
Hospitals
Others
Maternal Mental Health Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Maternal Mental Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Maternal Mental Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Maternal Mental Health.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Maternal Mental Health in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Maternal Mental Health industry.
Chapter 3: Detailed analysis of Maternal Mental Health companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Maternal Mental Healthrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antidepressants
- Interpersonal Psychotherapy
- Cognitive Behavioural Therapy
- Others
Applications
- Clinics
- Hospitals
- Others
Companies covered
- Lipocine
- Pfizer
- Viatris
- Bold Health
- Glaxo Smith Kline Inc.
- Alembic Pharmaceuticals Limited
- Mallinckrodt
- Sage Therapeutics, Inc.
- Bausch Health Companies Inc.
- Magellan Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Maternal Mental Health Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Antidepressants
- 1.2.3 Interpersonal Psychotherapy
- 1.2.4 Cognitive Behavioural Therapy
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Maternal Mental Health Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Clinics
- 1.3.3 Hospitals
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Maternal Mental Health Growth Trends by Region
- 1.5.1 Global Maternal Mental Health Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Maternal Mental Health Market Size by Region (2021-2026)
- 1.5.3 Maternal Mental Health Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Maternal Mental Health Market Dynamics
- 2.1 Maternal Mental Health Industry Trends
- 2.2 Maternal Mental Health Industry Drivers
- 2.3 Maternal Mental Health Industry Opportunities and Challenges
- 2.4 Maternal Mental Health Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Maternal Mental Health Revenue by Company (2021-2026)
- 3.2 Global Maternal Mental Health Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Maternal Mental Health Key Company Head office and Area Served
- 3.4 Global Maternal Mental Health Company, Product Type & Application
- 3.5 Global Maternal Mental Health Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Maternal Mental Health Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Maternal Mental Health Players Market Share by Revenue in 2025
- 3.6.3 2025 Maternal Mental Health Tier 1, Tier 2, and Tier 3
4 Maternal Mental Health Market by Type
- 4.1 Global Maternal Mental Health Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Maternal Mental Health Market Size by Type (2021-2032)
- 4.3 Global Maternal Mental Health Market Size Share by Type (2021-2032)
5 Maternal Mental Health Market by Application
- 5.1 Global Maternal Mental Health Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Maternal Mental Health Market Size by Application (2021-2032)
- 5.3 Global Maternal Mental Health Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Lipocine
- 6.1.1 Lipocine Company Information
- 6.1.2 Lipocine Business Overview
- 6.1.3 Lipocine Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Lipocine Maternal Mental Health Product Portfolio
- 6.1.5 Lipocine Recent Developments
- 6.2 Pfizer
- 6.2.1 Pfizer Company Information
- 6.2.2 Pfizer Business Overview
- 6.2.3 Pfizer Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Pfizer Maternal Mental Health Product Portfolio
- 6.2.5 Pfizer Recent Developments
- 6.3 Viatris
- 6.3.1 Viatris Company Information
- 6.3.2 Viatris Business Overview
- 6.3.3 Viatris Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Viatris Maternal Mental Health Product Portfolio
- 6.3.5 Viatris Recent Developments
- 6.4 Bold Health
- 6.4.1 Bold Health Company Information
- 6.4.2 Bold Health Business Overview
- 6.4.3 Bold Health Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Bold Health Maternal Mental Health Product Portfolio
- 6.4.5 Bold Health Recent Developments
- 6.5 Glaxo Smith Kline Inc.
- 6.5.1 Glaxo Smith Kline Inc. Company Information
- 6.5.2 Glaxo Smith Kline Inc. Business Overview
- 6.5.3 Glaxo Smith Kline Inc. Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Glaxo Smith Kline Inc. Maternal Mental Health Product Portfolio
- 6.5.5 Glaxo Smith Kline Inc. Recent Developments
- 6.6 Alembic Pharmaceuticals Limited
- 6.6.1 Alembic Pharmaceuticals Limited Company Information
- 6.6.2 Alembic Pharmaceuticals Limited Business Overview
- 6.6.3 Alembic Pharmaceuticals Limited Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Alembic Pharmaceuticals Limited Maternal Mental Health Product Portfolio
- 6.6.5 Alembic Pharmaceuticals Limited Recent Developments
- 6.7 Mallinckrodt
- 6.7.1 Mallinckrodt Company Information
- 6.7.2 Mallinckrodt Business Overview
- 6.7.3 Mallinckrodt Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Mallinckrodt Maternal Mental Health Product Portfolio
- 6.7.5 Mallinckrodt Recent Developments
- 6.8 Sage Therapeutics, Inc.
- 6.8.1 Sage Therapeutics, Inc. Company Information
- 6.8.2 Sage Therapeutics, Inc. Business Overview
- 6.8.3 Sage Therapeutics, Inc. Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Sage Therapeutics, Inc. Maternal Mental Health Product Portfolio
- 6.8.5 Sage Therapeutics, Inc. Recent Developments
- 6.9 Bausch Health Companies Inc.
- 6.9.1 Bausch Health Companies Inc. Company Information
- 6.9.2 Bausch Health Companies Inc. Business Overview
- 6.9.3 Bausch Health Companies Inc. Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Bausch Health Companies Inc. Maternal Mental Health Product Portfolio
- 6.9.5 Bausch Health Companies Inc. Recent Developments
- 6.10 Magellan Health
- 6.10.1 Magellan Health Company Information
- 6.10.2 Magellan Health Business Overview
- 6.10.3 Magellan Health Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Magellan Health Maternal Mental Health Product Portfolio
- 6.10.5 Magellan Health Recent Developments
7 North America
- 7.1 North America Maternal Mental Health Market Size (2021-2032)
- 7.2 North America Maternal Mental Health Market Size by Type
- 7.2.1 North America Maternal Mental Health Market Size by Type (2021-2026)
- 7.2.2 North America Maternal Mental Health Market Size by Type (2027-2032)
- 7.2.3 North America Maternal Mental Health Market Share by Type (2021-2032)
- 7.3 North America Maternal Mental Health Market Size by Application
- 7.3.1 North America Maternal Mental Health Market Size by Application (2021-2026)
- 7.3.2 North America Maternal Mental Health Market Size by Application (2027-2032)
- 7.3.3 North America Maternal Mental Health Market Share by Application (2021-2032)
- 7.4 North America Maternal Mental Health Market Size by Country
- 7.4.1 North America Maternal Mental Health Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Maternal Mental Health Market Size by Country (2021-2026)
- 7.4.3 North America Maternal Mental Health Market Size by Country (2027-2032)
- 7.4.4 North America Maternal Mental Health Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Maternal Mental Health Market Size (2021-2032)
- 8.2 Europe Maternal Mental Health Market Size by Type
- 8.2.1 Europe Maternal Mental Health Market Size by Type (2021-2026)
- 8.2.2 Europe Maternal Mental Health Market Size by Type (2027-2032)
- 8.2.3 Europe Maternal Mental Health Market Share by Type (2021-2032)
- 8.3 Europe Maternal Mental Health Market Size by Application
- 8.3.1 Europe Maternal Mental Health Market Size by Application (2021-2026)
- 8.3.2 Europe Maternal Mental Health Market Size by Application (2027-2032)
- 8.3.3 Europe Maternal Mental Health Market Share by Application (2021-2032)
- 8.4 Europe Maternal Mental Health Market Size by Country
- 8.4.1 Europe Maternal Mental Health Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Maternal Mental Health Market Size by Country (2021-2026)
- 8.4.3 Europe Maternal Mental Health Market Size by Country (2027-2032)
- 8.4.4 Europe Maternal Mental Health Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Maternal Mental Health Market Size (2021-2032)
- 9.2 China Maternal Mental Health Market Size by Type
- 9.2.1 China Maternal Mental Health Market Size by Type (2021-2026)
- 9.2.2 China Maternal Mental Health Market Size by Type (2027-2032)
- 9.2.3 China Maternal Mental Health Market Share by Type (2021-2032)
- 9.3 China Maternal Mental Health Market Size by Application
- 9.3.1 China Maternal Mental Health Market Size by Application (2021-2026)
- 9.3.2 China Maternal Mental Health Market Size by Application (2027-2032)
- 9.3.3 China Maternal Mental Health Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Maternal Mental Health Market Size (2021-2032)
- 10.2 Asia Maternal Mental Health Market Size by Type
- 10.2.1 Asia Maternal Mental Health Market Size by Type (2021-2026)
- 10.2.2 Asia Maternal Mental Health Market Size by Type (2027-2032)
- 10.2.3 Asia Maternal Mental Health Market Share by Type (2021-2032)
- 10.3 Asia Maternal Mental Health Market Size by Application
- 10.3.1 Asia Maternal Mental Health Market Size by Application (2021-2026)
- 10.3.2 Asia Maternal Mental Health Market Size by Application (2027-2032)
- 10.3.3 Asia Maternal Mental Health Market Share by Application (2021-2032)
- 10.4 Asia Maternal Mental Health Market Size by Country
- 10.4.1 Asia Maternal Mental Health Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Maternal Mental Health Market Size by Country (2021-2026)
- 10.4.3 Asia Maternal Mental Health Market Size by Country (2027-2032)
- 10.4.4 Asia Maternal Mental Health Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Maternal Mental Health Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Maternal Mental Health Market Size by Type
- 11.2.1 South America, Middle East & Africa Maternal Mental Health Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Maternal Mental Health Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Maternal Mental Health Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Maternal Mental Health Market Size by Application
- 11.3.1 South America, Middle East & Africa Maternal Mental Health Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Maternal Mental Health Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Maternal Mental Health Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Maternal Mental Health Market Size by Country
- 11.4.1 South America, Middle East & Africa Maternal Mental Health Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Maternal Mental Health Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Maternal Mental Health Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Maternal Mental Health Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst